2. UroToday Home
  3. Video Lectures

AUA 2025 Conference Videos

Artificial Intelligence and Machine Learning in Bladder Cancer Pathology and Clinical Decision-Making - Hikmat Al-Ahmadie & Alexandre Zlotta
An Artificial Intelligence Predictive Biomarker for Response to BCG vs Gemcitabine-Docetaxel for High Grade NMIBC - Vignesh Packiam
Computational Histology AI's Potential in Refining NMIBC Prognostication - Bryn Launer
Computational Histology AI Guides Treatment Selection for Bladder Cancer Patients - Vignesh Packiam
AUA 2025 Highlights: Advances in Advanced Kidney Cancer - Kelvin Moses
Subgroup Analysis Confirms Darolutamide Efficacy in Black Prostate Cancer Patients - Quoc-Dien Trinh
AUA 2025 Highlights: Advances in Kidney Cancer - Elizabeth Koehne
AUA 2025 Highlights: Advances in Non-Muscle Invasive Bladder Cancer - Patrick Hensley & Janet Kukreja
Sasanlimab Immunotherapy + BCG in BCG-Naive Bladder Cancer - Sam Chang
Real-World EV-301 Data: Enfortumab Vedotin in Trial-Ineligible Patients - Kazutaka Nakamura
Examining Under-Staging in BCG-Unresponsive Bladder Cancer Patients Undergoing Radical Cystectomy - Katharina Oberneder
SunRISe-1 Trial: Bladder-Sparing Results for BCG-Unresponsive Disease - Felix Guerrero-Ramos
Actinium-PSMA J591 After Prior Lutetium Therapy in Metastatic Prostate Cancer - Scott Tagawa
Surgical Outcomes in High-Risk Prostate Cancer: PSMA-PET vs Conventional Imaging - Alessandro Viti
Efficacy of TAR-200 in Non-Muscle Invasive Bladder Cancer: 1-Year Outcomes - Joseph Jacob
ADVANCED-2 Trial: TARA-002 in BCG-Naive High-Risk NMIBC - Brian Mazzarella
Optimizing TURBT: Balancing Surgical Skill and Advanced Technology - Mark Tyson & Vignesh Packiam
PIVOT-006 Trial: Cretostimogene Grenadenorepvec for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Max Kates
BCG Efficacy in Bladder Cancer Amid Emerging Immunotherapy Combinations - Joshua Meeks & Benjamin Pradere
BCG-Unresponsive Bladder CIS: Real-World Data Reveals High Recurrence and Treatment Gaps - Stephen Williams
Clinical Trial Access Barriers for Veterans with Prostate Cancer - Madison Krischak
MoonRISe-1 Trial: Evaluating TAR-210 for FGFR-Altered Intermediate-Risk NMIBC - Roger Li
EMBARK Analysis: Testosterone Recovery Post-ADT in High-Risk Prostate Cancer Patients - Stephen Freedland
Multicenter European Trial Investigates Gem/Doce for Non-Muscle Invasive Bladder Cancer - Pietro Scilipoti
Pre-Cystectomy ctDNA Levels and Metastatic Recurrence in Bladder Cancer Patients - Reuben Ben-David
International Validation of AI Tool for Stratifying Bladder Cancer Progression Risk - Jethro Kwong
Cystectomy vs. Bladder Preservation: Weighing Options for Muscle-Invasive Bladder Cancer - Bogdana Schmidt & Kent Mouw
AI Risk Calculator Outperforms EAU Models for Bladder Cancer Prognosis - Alexandre Zlotta
HSPC to mCRPC: Management Current Approaches and Future Developments - Michael Cookson & Jason Efstathiou
Active Surveillance vs TURBT for Low-Grade Ta Bladder Cancer - Morgan Rouprêt & Laura Bukavina
Practice-Changing Advances in Urothelial Cancer: Highlights Across Disease States - Alice Yu
TRITON3 Subgroup Analysis: Rucaparib Benefits BRCA+ Patients with Liver Mets - David Morris
ctDNA in Bladder Cancer: Prognostic Value and Ongoing Clinical Trials - Jonathan Rosenberg & Petros Grivas
SunRISe-1 Trial Shows TAR-200 Efficacy in BCG-Unresponsive Bladder Cancer - Felix Guerrero-Ramos
Combining Alpha and Beta Emitters in PSMA-Targeted Prostate Cancer Therapy - Scott Tagawa
CISTO Study: Comparing Cystectomy vs. Bladder-Sparing Therapy for Recurrent NMIBC - John Gore
PSMA-PET Improves Metastasis-Free Survival in Salvage Radiotherapy for Prostate Cancer - Antony Pellegrino
PRECISION Data Platform Reveals mCRPC Treatment Outcomes in Urology Practices - Neal Shore
NIAGARA Study: Durvalumab Improves DFS in Muscle-Invasive Bladder Cancer Post-Cystectomy - Joshua Meeks
Real-World Implementation of Biomarkers for Microhematuria Workup - Ronald Loo & Christopher Filson
AUA Microhematuria Guidelines 2025 - Daniel Barocas
Real-World Data Improves NMIBC Risk Assessment with Blue Light Technology - Siamak Daneshmand & Boris Gershman
Platform Reduces Unnecessary Cystoscopies for Hematuria Patients - John Sfakianos
ARANOTE Study Shows Benefits of Deep PSA Response with Darolutamide - Neal Shore
Cost-Effectiveness of 89Zr-DFO-Girentuximab PET Scan for Small Renal Mass Diagnosis - Pratik Kanabur
Health-Related Quality Outcomes for Pre-Chemotherapy mCRPC Treatment - Neal Shore
CORE-008 Trial Cohort CX: Combining Cretostimogene Grenadenorepvec and Gemcitabine for Bladder Cancer - Trinity Bivalacqua
BOND-003 Cohort P Results for BCG-Unresponsive Papillary Bladder Tumors - Mark Tyson
CORE-008 Cohort A: Cretostimogene in BCG-Naïve High-Risk NMIBC – Trial Design & Update - Trinity Bivalacqua
Treatment Intensification Strategies for High-Risk Prostate Cancer Patients - Aaron Berger
BOND-003 Cohort C Trial Results for Cretostimogene Grenadenorepvec in BCG-Unresponsive Bladder Cancer - Mark Tyson
CUT-less Trial Aims to Eliminate Secondary TURBT in Non-Muscle Invasive Bladder Cancer - Francesco Del Giudice
Evaluating Risk Stratification Models for Blue Light Cystoscopy in Bladder Cancer - Sia Daneshmand & Boris Gershman
Biomarkers for Gemcitabine Docetaxel in Non-Muscle Invasive Bladder Cancer - Vignesh Packiam
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel
Optimizing Prostate Biopsy Specimens for Improved Pathological Diagnosis - Daniel Wiener
Prospective Randomized Evaluation of Viewing CT-Based Immersive Virtual Reality Imaging Prior To Laparoscopic/Robotic Partial Nephrectomy: Impact on Surgical Planning and Outcomes "Presentation" - Eman Chaudhri
Pushing Back: A Comparative Analysis of the Retropulsive Forces Generated by Modern Laser Systems Using an In Vitro Model of Laser Lithotripsy "Presentation" - Aymon Ali
First In-Vivo Evaluation of Pharmaceutical Modulation of Porcine Ureteral Distensibility "Presentation" - Seyedamirvala Saadat
Air Force #1: Development and Initial Clinical Evaluation of an Easily Assembled, Cost-Effective Force Sensor for the Safe Passage of Ureteral Access "Presentation" - Bruce Gao
Porcine Bladder Augmentation Using Medical Grade Titanium Foil: Initial Experience "Presentation" - Aymon Ali
Electromotive Drug Administration (EMDA) in the Porcine Ureter: First Report of In Vivo Ureteral Dilation Following Alfuzosin Infusion "Presentation" - Victor Pham
Comparative Analysis of Lubricity in Ureteral Access Sheaths, Ureteral Dilators, and Urethral Dilators Using an Ex Vivo Porcine Ureteral Model "Presentation" - Brandon Camp
Stop the Flow: PCNL Outcomes Under Saline-Restricted Irrigation Conditions "Presentation" - Tyler Lunow-Luke
Assessment of the Accuracy of 3D Slicer vs. Ellipsoid Formulae for Stone Volume Measurement: Size Matters! "Presentation" - Seyed Amiryaghoub Lavasani
Comparative Evaluation of Temperature Generation during Laser Lithotripsy: Thulium Fiber Laser, Pulsed Thulium:YAG, and Holmium:YAG with Pulse Modulation "Presentation" - Bruce Gao
Advancing Microhematuria Evaluation: The Impact of Urinary Biomarkers and Updated Guidelines - Jay D. Raman & Yair Lotan
Refining Risk in NMIBC: Intermediate Stratification, TURBT Quality, and Emerging Options - Katie Murray
The Details Are in the Core: Advancing Prostate Tissue Collection - James Wysock